JBSS 39.38 John B. Sanfilippo & Son $JBSS Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 11:01 AM

JBSS 39.38 John B. Sanfilippo & Son $JBSS Hit a 52 week high of 39.38 Closing the day 09:30 at 39.38 -0.05 -0.13% With a day low of 39.38 and a total volume of 608.

JBSS Recent Posts: http://investorshangout.com/Sanfilippo-John-B...BSS-54529/

JBSS John B. Sanfilippo & Son Recent Headline News

John B. Sanfilippo & Son, Inc. to Present at the Southwest IDEAS Investor Conference on November 19th & 20th in Dallas
Business Wire - Thu Nov 13, 4:13PM CST
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS), today announced that Mike Valentine, Chief Financial Officer and Frank Pellegrino, Sr. Vice President of Finance will present at the Southwest IDEAS Investor Conference on Thursday, November 20, 2014 at the Marriott - Quorum Hotel in Addison, Texas. John B. Sanfilippo & Son, Inc.'s presentation is scheduled to begin at 1:50 p.m. Central. The presentation will be webcast live and may be accessed at the conference website, www.IDEASConferences.com, or in the investor relations section of the company's website: http://www.jbssinc.com.
JBSS: 39.41 (-0.02)

John B. Sanfilippo & Son declares $1.50 dividend
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:47PM CDT

JBSS: 39.41 (-0.02)

John B. Sanfilippo & Son, Inc. Board Declares Special Cash Dividend of $1.50 per share of Common Stock and $1.50 per share of Class A Common Stock
Business Wire - Tue Oct 28, 4:04PM CDT
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) (the "Company"

today announced that its Board of Directors (the "Board"

declared a special cash dividend (the "Dividend"

of $1.50 per share on all issued and outstanding shares of Common Stock of the Company and $1.50 per share on all issued and outstanding shares of Class A Common Stock of the Company.
JBSS: 39.41 (-0.02)

John B. Sanfilippo & Son Is A Strong Buy For Long Term Investors
Jaxon Research - at Seeking Alpha - Tue Oct 28, 10:24AM CDT

JBSS: 39.41 (-0.02)

Update: John B. Sanfilippo & Son's Weak Fiscal Q1'15
Marshall Hargrave - at Seeking Alpha - Tue Oct 28, 1:55AM CDT

JBSS: 39.41 (-0.02)

John B Sanfilippo & Son's (JBSS) CEO Jeffrey Sanfilippo on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 1:50PM CDT

JBSS: 39.41 (-0.02)

John B. Sanfilippo & Son EPS of $0.53
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 3:27PM CDT

JBSS: 39.41 (-0.02)

John B. Sanfilippo & Son, Inc. Net Sales Increased by 16% on Higher Pricing and Strong Sales Volume
Business Wire - Thu Oct 23, 3:10PM CDT
--Net sales increased by 16.0%
JBSS: 39.41 (-0.02)

Shares of JBSS Up 43.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 20, 9:09AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 6 months, John B. Sanfilippo & Son has returned 43.68% as of today's recent price of $35.03.
JBSS: 39.41 (-0.02)

John B. Sanfilippo & Son, Inc. 1st Quarter Fiscal 2015 Operating Results Conference Call
GlobeNewswire - Fri Oct 17, 4:00PM CDT
John B. Sanfilippo & Son, Inc. (Nasdaq:JBSS), a major processor and distributor of snack and recipe nut products, will hold its quarterly conference call to discuss first quarter fiscal 2015 operating results on Friday, October 24, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). First quarter fiscal 2015 results are expected to be released after the market closes on Thursday, October 23, 2014.
JBSS: 39.41 (-0.02)

Today In SA PRO: Tuesday, October 14
SA PRO Top Ideas - at Seeking Alpha - Wed Oct 15, 4:00AM CDT
Outstanding Performance Award Winner #1: Top Short Idea on MCHX (Marchex, Inc.) by Ariana Research, published July 11, 2014. Return to date: +68% (See author update » ) Outstanding Performance Award Winner #2: PRO Short Idea on ITT...
WATT: 9.58 (+0.32), JBSS: 39.41 (-0.02)

John B. Sanfilippo & Son Has Returned 34.3% Since SmarTrend Recommendation (JBSS)
Comtex SmarTrend(R) - Fri Oct 10, 5:11PM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 5 months, John B. Sanfilippo & Son has returned 34.33% as of today's recent price of $32.75.
JBSS: 39.41 (-0.02)

John B. Sanfilippo & Son Up 32.9% Since SmarTrend Uptrend Call (JBSS)
Comtex SmarTrend(R) - Fri Oct 03, 4:45PM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 5 months, John B. Sanfilippo & Son has returned 32.90% as of today's recent price of $32.40.
JBSS: 39.41 (-0.02)

Fisher Announces Statewide Campaign and $40,000 Donation to Feeding Texas
PR Newswire - Fri Oct 03, 9:00AM CDT
Fisher® Nuts announced a statewide campaign to bring Texas communities together to help feed hungry families this holiday season. In its third year partnering with Feeding Texas (formerly the Texas Food Bank Network) for the Fisher Shares & Cares campaign, Fisher is donating $40,000 that will be used to help feed 400,000 Texans throughout the season.
JBSS: 39.41 (-0.02)

33.6% Return Seen to Date on SmarTrend John B. Sanfilippo & Son Call (JBSS)
Comtex SmarTrend(R) - Fri Sep 26, 10:58AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 5 months, John B. Sanfilippo & Son has returned 33.55% as of today's recent price of $32.56.
JBSS: 39.41 (-0.02)

Shares of JBSS Up 32.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Sep 19, 9:36AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 5 months, John B. Sanfilippo & Son has returned 32.32% as of today's recent price of $32.26.
JBSS: 39.41 (-0.02)

Uptrend Call Working As John B. Sanfilippo & Son Stock Rises 33.0% (JBSS)
Comtex SmarTrend(R) - Fri Sep 12, 9:10AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 4 months, John B. Sanfilippo & Son has returned 32.98% as of today's recent price of $32.42.
JBSS: 39.41 (-0.02)

Fisher Nuts and Chef Alex Guarnaschelli Announce Second Annual "My Fresh Twist" Recipe Contest
PR Newswire - Tue Sep 09, 10:45AM CDT
Fisher® Nuts has announced the second annual "My Fresh Twist" recipe contest today. Beginning now through October 21, 2014 consumers are invited to submit an original recipe using walnuts, almonds or pecans to www.myfreshtwist.com for a chance to win a grand prize that includes a trip for two to New York City to meet Chef Alex Guarnaschelli.
JBSS: 39.41 (-0.02)

John B. Sanfilippo & Son Has Returned 27.8% Since SmarTrend Recommendation (JBSS)
Comtex SmarTrend(R) - Thu Aug 28, 10:58AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 4 months, John B. Sanfilippo & Son has returned 27.75% as of today's recent price of $31.15.
JBSS: 39.41 (-0.02)

Sanfilippo (John B.) & Son Inc. (JBSS) Stock Research Links

JBSS Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...